More specifically, matched resection tissue from pre-treatment and 2–9 months post-treatment showed a significant increase in CD4+ and CD8+ T cells within the tumour as well as areas adjacent and distant from where G207 was inoculated [16]. This evidence concerns the gene CD8A and neoplasm.